In May 1956, Aventis Pharma Limited was established as Hoechst Fedco Pharma Private Ltd. With 50.1% holding of paid-up share capital, Sanofi-aventis is the major shareholder of Aventis Pharma Ltd.
Aventis is currently present in over 100 countries with its global headquarters in Paris, France. The total employee strength worldwide is about 100,000, including 11000 scientists. Product portfolio of Aventis includes medicines in the area of cardiovascular disease, thrombosis, diabetes, bone disease, epilepsy and cancer. It has 20 research centers in three continents, with R&D budget of about 4 billion euros.
Aventis Pharma Ltd. India has 2 state-of-art manufacturing facilities at Ankleshwar (Gujarat) and at Verna (Goa). These sites have been identified as the global sourcing units.
The company is working to bring innovative products so as to make the necessary treatments more widely available. In India it has employee strength of about 1840.
54/A, Sir Mathuradas Vasanji Road,
Mumbai – 400 093
Quarterly Results of Aventis
|Dec 2006(3 rd quarter)||Sept 2006(2nd quarter)||Dec 2005(3 rd quarter)|
|% Change (Over Sep 2006)||% Change (Over Dec 2005)|
Annual Results of Aventis
|(12 Months)||(12 Months)||% Changes|